Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.

about

Early thrombomodulin-α administration outcome for acute disseminated intravascular coagulopathy in gastrointestinal surgery.

P2860

Q37629721-C41ECC8A-B58B-4598-99BB-B50F44C587A5

P2860

Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.

Item

http://www.wikidata.org/entity/Q40741273

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Efficacy of recombinant human ...... in the gastroenterology field.

@en

type

Item

label

Efficacy of recombinant human ...... in the gastroenterology field.

@en

prefLabel

Efficacy of recombinant human ...... in the gastroenterology field.

@en

P1476

Efficacy of recombinant human ...... in the gastroenterology field.

@en

P2093

Akihito Nagahara

http://www.w3.org/2001/XMLSchema#string

Hiroaki Saito

http://www.w3.org/2001/XMLSchema#string

Hiroya Ueyama

http://www.w3.org/2001/XMLSchema#string

Jinkan Sai

http://www.w3.org/2001/XMLSchema#string

Junko Kato

http://www.w3.org/2001/XMLSchema#string

Nobuhito Taniki

http://www.w3.org/2001/XMLSchema#string

Ryo Kanazawa

http://www.w3.org/2001/XMLSchema#string

Ryo Shimizu

http://www.w3.org/2001/XMLSchema#string

Shuichiro Shiina

http://www.w3.org/2001/XMLSchema#string

Sumio Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis and clinical features of acute cholangitis accompanied by shock.

Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model

The interactions between inflammation and coagulation.

Expert consensus for the treatment of disseminated intravascular coagulation in Japan.

Inflammation and coagulation.

A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.

Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.

Acute cholangitis: a histopathologic study.

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

P304

457-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2015.464

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277351045

http://www.w3.org/2001/XMLSchema#string

P698

26171148

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

sepsis

P932

4486978

http://www.w3.org/2001/XMLSchema#string

Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.

about

P2860

P2860

Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932